[HTML][HTML] Involvement of GLUT1-mediated glucose transport and metabolism in gefitinib resistance of non-small-cell lung cancer cells

S Suzuki, M Okada, H Takeda, K Kuramoto… - Oncotarget, 2018 - ncbi.nlm.nih.gov
… While our findings thus underscore the role of GLUT1-mediated glucose metabolism in
gefitinib resistance, it may be worth noting here that, consistent with a previous observation that …

[HTML][HTML] Effect of ABCG2/BCRP expression on efflux and uptake of gefitinib in NSCLC cell lines

M Galetti, PG Petronini, C Fumarola, D Cretella… - PloS one, 2015 - journals.plos.org
… drug transport systems, in particular inhibiting MPP, glucose … drug resistance by inhibiting
the transporter function of … we investigated whether gefitinib inhibited the transporter function of …

[HTML][HTML] Apigenin combined with gefitinib blocks autophagy flux and induces apoptotic cell death through inhibition of HIF-1α, c-Myc, p-EGFR, and glucose metabolism …

ZS Chen, D Tian, X Liao, Y Zhang, J Xiao… - Frontiers in …, 2019 - frontiersin.org
… In the current study, as shown in Figure 8, we show that a combination of apigenin +
gefitinib in EGFR-mutated, TKI-resistant NSCLC will induce metabolic stress and energetic …

Monitoring tumor glucose utilization by positron emission tomography for the prediction of treatment response to epidermal growth factor receptor kinase inhibitors

H Su, C Bodenstein, RA Dumont, Y Seimbille… - Clinical Cancer …, 2006 - AACR
… as models for gefitinib-sensitive and gefitinib-resistant cells. … Furthermore, gefitinib-resistant
cell lines did not show a … lines, gefitinib leads to the translocation of glucose transporters from …

[HTML][HTML] Increased glutamine anabolism sensitizes non-small cell lung cancer to gefitinib treatment

L Wang, W Peng, T Wu, P Deng, YL Zhao - Cell death discovery, 2018 - nature.com
… However, gefitinib treatment only decreased the glutamine … level of glucose consumption
when treated with gefitinib, but the … not glucose metabolism, correlate with gefitinib resistance in …

[HTML][HTML] Resistance to the tyrosine kinase inhibitor axitinib is associated with increased glucose metabolism in pancreatic adenocarcinoma

CD Hudson, T Hagemann, SJ Mather, N Avril - Cell death & disease, 2014 - nature.com
… of glucose transporter-1 (Glut-1) transporters from cytosolic … that PDAC resistance to axitinib
results in increased glucose … MET amplification leads to gefitinib resistance in lung cancer …

[HTML][HTML] Gefitinib-mediated reactive oxygen specie (ROS) instigates mitochondrial dysfunction and drug resistance in lung cancer cells

IS Okon, KA Coughlan, M Zhang, Q Wang… - Journal of Biological …, 2015 - ASBMB
… into cellular perturbations that accompany acquired gefitinib resistance in lung cancer cells.
… , we generated gefitinib-resistant H1650 clone by long-term, chronic culture under gefitinib

The phosphatidylinositol-3-kinase inhibitor PX-866 overcomes resistance to the epidermal growth factor receptor inhibitor gefitinib in A-549 human non–small cell …

NT Ihle, G Paine-Murrieta, MI Berggren, A Baker… - Molecular cancer …, 2005 - AACR
gefitinib. We also report on the toxicity of long-term administration of PX-866, showing that it
increases blood glucosetransporter-4 to the plasma membrane (45). It has been suggested …

PKM2/PDK1 dual-targeted shikonin derivatives restore the sensitivity of EGFR-mutated NSCLC cells to gefitinib by remodeling glucose metabolism

H Lin, H Han, M Yang, Z Wen, Q Chen, Y Ma… - European Journal of …, 2023 - Elsevier
gefitinib (IC 50 … to gefitinib. Collectively, these data demonstrate that E5, a dual inhibitor
of PKM2/PDK1, may be a promising adjunct to gefitinib in the treatment of EGFR-TKIs resistant

Glucose metabolism‐targeted therapy and withaferin A are effective for epidermal growth factor receptor tyrosine kinase inhibitor‐induced drug‐tolerant persisters

K Kunimasa, T Nagano, Y Shimono, R Dokuni… - Cancer …, 2017 - Wiley Online Library
… A effectively suppressed gefitinib-resistant tumor growth. … gefitinib-induced DTPs by exposing
PC9 cells to gefitinib (2 μM… showed upregulation of the glucose transporters Glut1 and Glut3…